Paclitaxel
NDC Package 0069-0076-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Paclitaxel is used to treat various types of cancer. Marketed by Pfizer Laboratories Div Pfizer Inc., this product is identified by NDC 0069-0076 and is authorized under FDA application ANDA091540.

Identification & Billing

NDC Package Code
0069-0076-01
Package Description
16.7 mL in 1 VIAL
Product Code
0069-0076
11-Digit Billing Format
00069007601
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
16.7 ML

Clinical Specifications

Proprietary Name
Paclitaxel
Dosage Form
-
Usage Information
Paclitaxel is used to treat various types of cancer. It is a cancer chemotherapy drug that works by slowing or stopping cancer cell growth.

Regulatory & Marketing

Labeler Name
Pfizer Laboratories Div Pfizer Inc.
FDA Application #
ANDA091540
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-30-2011
End Marketing Date
12-31-2016
Listing Expiration
12-31-2016
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0069-0076-01 identifies a specific commercial package of 16.7 ml in 1 vial of Paclitaxel, labeled by Pfizer Laboratories Div Pfizer Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pfizer Laboratories Div Pfizer Inc. on September 30, 2011. The current certification is valid through December 31, 2016.

What are the primary indications for this medication?

Paclitaxel is used to treat various types of cancer. It is a cancer chemotherapy drug that works by slowing or stopping cancer cell growth.

How is this Pfizer Laboratories Div Pfizer Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00069007601. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 16.7 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0069-0076-01
11-Digit CMS (5-4-2)
00069-0076-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.